A significant breakthrough in cancer research is arising with the use of mini-antibodies to reactivate mutated p53. This crucial malignant suppressor protein is frequently disabled in various types of malignancies, https://pr8bookmarks.com/story22080084/vhh-fragments-restore-tumor-suppressor-p53-a-new-pathway-for-malignant-therapy